Telehealth’s New Test: Can the System See It?

Telehealth is past the stage where the main question was whether a visit could happen at all. The discussion increasingly centers around something less glamorous and more consequential: can that visit be recognized, measured, and paid for inside the healthcare system?

That shift may sound bureaucratic, but bureaucracy is where healthcare often lives. Standards, codes, documentation, and organizational structure are becoming the real battleground. In that sense, telehealth is moving from being a convenience layer to something closer to a compliance exercise with a video window attached.

From access tool to audit trail

One clear signal is CMS folding telehealth encounters into quality reporting when they are payable under the Physician Fee Schedule. That is not just administrative housekeeping. It suggests virtual care is being absorbed into the same reporting and compliance scaffolding as in-person care.

At the same time, the risk-adjustment exclusion for some telehealth-eligible codes points to the other side of the story. Recognition is selective. Not every virtual interaction counts the same way, and not every code carries the same weight. In healthcare, being “seen” by the system is not always the same as being fully counted.

Telehealth is becoming less of a standalone channel and more of a test of whether the system can recognize the work behind the visit.

The workflow now matters as much as the visit

The practical implication is straightforward: telehealth providers are no longer judged only on whether they can connect a patient and clinician. They are increasingly judged on whether the whole workflow is legible.

• Consent has to be documented.
• Billing has to line up.
• Triage has to make sense.
• EHR integration has to hold together.
• Coding has to survive scrutiny.
• Corporate structure has to fit the rules.

That is a lot of moving parts for something that is often marketed as simple. The joke, if there is one, is that telehealth may have started as a faster way to see a doctor and ended up as a very organized way to prove you saw one.

Convenience is no longer enough

This also changes the competitive landscape. The companies most likely to stand out are not necessarily the ones with the slickest video product or the fastest scheduling flow. Those features still matter, but they are no longer the whole story.

The stronger position appears to belong to companies that can plug telehealth into value-based care, chronic disease management, or hospital capacity relief. In those settings, telehealth may function less like a commodity visit vendor and more like infrastructure. That is a meaningful distinction, even if it is not always a clean one.

But there is a catch. The more telehealth depends on regulatory recognition, the more exposed it becomes to rule changes. A model built on loosely interpreted billing or ambiguous provider arrangements may scale quickly, then compress just as quickly if the rules tighten. In healthcare, a good regulatory mood can look a lot like a business model until it doesn’t.

The real sorting mechanism

So the market’s sorting mechanism is shifting. The question is no longer simply, “Who can do telehealth?” It is becoming, “Who can survive being made visible to the system?”

That is a tougher test, but also a more revealing one. Telehealth’s real product may not be the visit itself. It may be legibility: the ability to make care visible enough to be recognized, counted, and paid for without falling apart under scrutiny.

And in healthcare, being legible is often the difference between a useful service and a durable one.